Key Insights Significant control over GoodRx Holdings by individual investors implies that the general public has ...
GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the oversold stocks to buy now. On January 5, Bank of America analyst Allen Lutz ...
Shares of GoodRx (GDRX), which provides drug coupons for discounts on medications, jumped over 5% on Thursday afternoon. This came after the company joined American retail pharmacies and chain drug ...
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...
GoodRx announced that eligible self-paying patients can now access all strengths of Ozempic and Wegovy pens for $499 per month through its platform, effective immediately. The collaboration marks the ...